Mégarbané–Loiselet Syndrome

Mégarbané–Loiselet syndrome is an extremely rare genetic condition reported in a single family. It causes birth defects of the branchial arches in the neck and malformations of the ears. Children have congenital hearing loss that can be conductive, sensorineural, or mixed. Imaging may show narrow internal auditory canals. Some people have branchial cysts or fistulas on the side of the neck, abnormal fifth fingers, strabismus, short height, light skin patches like vitiligo, and mild learning problems. Kidney and ureter problems are not part of this syndrome, which helps doctors tell it apart from the more common branchio-oto-renal (BOR) spectrum. The inheritance pattern is autosomal dominant. orpha.net+2Genetic Rare Diseases Info Center+2

Mégarbané–Loiselet syndrome (also called Branchiogenic Deafness Syndrome). It’s an extremely rare congenital condition reported in a single family, with autosomal-dominant inheritance and core features that include branchial cysts/fistulae, ear malformations, congenital hearing loss (conductive, sensorineural, or mixed), hypoplastic internal auditory canals, strabismus, trismus, fifth-finger anomalies, short stature, and mild learning difficulties—notably without renal/ureteral anomalies. There is no disease-specific curative drug; management is supportive and multidisciplinary (ENT, audiology, speech, ophthalmology, craniofacial surgery, genetics). cags.org.ae+4orpha.net+4rarediseases.info.nih.gov+4

Mégarbané–Loiselet syndrome is a genetic condition present from birth. It changes how parts of the neck and ears develop, leading to small cysts or small tubes in the neck (branchial cysts or fistulae), unusual ear shape, and hearing loss. The ear canals inside the skull can be under-developed. Eye alignment can be off (strabismus). The mouth can open less easily (trismus). The little fingers may look different, and height may be short. Thinking and learning are usually near normal or only mildly affected. The condition seems to run in families in a pattern where one affected parent can pass it to a child (autosomal dominant). Because it is so rare, doctors treat symptoms one by one—protecting hearing early, supporting speech and learning, and surgically correcting neck or ear problems when helpful. orpha.net+2rarediseases.info.nih.gov+2

A key paper first described this condition as “a new dominant branchiogenic-deafness syndrome with internal auditory canal hypoplasia and abnormal extremities.” That report established the core features and the dominant inheritance in the family studied. onlinelibrary.wiley.com

Other names

• Branchiogenic deafness syndrome

• Branchiogenic hearing loss syndrome

• Mégarbané–Loiselet syndrome (MLS)
  These names are used by rare disease catalogs and patient-advocacy summaries. orpha.net+1

Types

Because this syndrome has been seen in only one family, doctors do not split it into formal “subtypes.” Clinically, specialists describe types by the kind of hearing loss and branchial anomaly, which helps with testing and treatment planning:

1. Hearing-loss types

• Conductive hearing loss (problem in outer/middle ear).

• Sensorineural hearing loss (inner ear or auditory nerve).

• Mixed hearing loss (both together).
  These three categories are standard in audiology and are specifically noted within MLS. MSD Manuals+2Frontiers+2

2. Branchial-anomaly types

• Cysts in the side of the neck.

• Sinuses (blind-ending tracts).

• Fistulas (tracts that open to skin and throat).
  These are standard embryologic categories of branchial anomalies and are reported in MLS. PMC+2NCBI+2

Causes

Important note: Because MLS has been described in only one family, the exact gene change is still unknown. Doctors therefore explain “causes” in terms of how development can go wrong in the neck and ear, and how this leads to the MLS picture. Below are 20 plausible developmental and clinical causes/contributors supported by what we know about MLS and closely related conditions; where evidence is indirect (from branchial-arch and congenital hearing-loss literature), this is stated.

1. Autosomal-dominant inheritance within the reported family—the trait passes from an affected parent to child. (Direct MLS evidence.) onlinelibrary.wiley.com

2. Abnormal development of branchial arches, which form parts of the neck and ear. (General embryology evidence.) NCBI

3. Second branchial cleft anomalies (most common class of branchial problems) leading to cysts, sinuses, or fistulas. (General evidence; fits MLS phenotype.) sciencedirect.com+1

4. Malformed external or middle ear structures causing conductive loss. (General hearing-loss mechanisms and MLS summaries.) MSD Manuals+1

5. Inner ear or auditory nerve underdevelopment causing sensorineural loss. (Audiology framework and MLS summaries.) Frontiers+1

6. Internal auditory canal (IAC) hypoplasia, specifically reported in the original MLS family, limiting the nerve space. (Direct MLS evidence.) onlinelibrary.wiley.com

7. Craniofacial patterning errors during early face and ear formation. (Embryology background that explains branchial and ear changes.) optecoto.com

8. Neural crest migration issues, which contribute to branchial arch and ear tissues. (Embryology background.) optecoto.com

9. Failure of normal branchial cleft involution, leaving residual tracts. (Branchial anomaly mechanism.) PMC

10. Abnormal ossicle formation or fixation (malleus, incus, stapes) reducing sound conduction. (Audiology/ENT background.) MSD Manuals

11. Eustachian tube dysfunction from ear malformations, worsening conductive loss. (ENT background.) MSD Manuals

12. Temporal bone structural anomalies associated with congenital hearing loss. (Radiologic/audiologic background; fits MLS imaging.) sciencedirect.com

13. Developmental eye-muscle miswiring explaining strabismus in summaries. (MLS summaries; mechanism inferred.) orpha.net

14. Limb bud patterning differences explaining abnormal fifth fingers. (MLS summaries; general limb-patterning background.) orpha.net

15. Pigment-cell distribution changes producing vitiligo-like patches. (Phenotype noted in MLS summaries; mechanism inferred.) orpha.net

16. Generalized growth regulation differences explaining short stature. (Phenotype noted; mechanism inferred.) orpha.net

17. Neurodevelopmental differences behind mild learning issues. (Phenotype noted; general neurodevelopment evidence.) orpha.net

18. Non-involvement of kidneys—not a cause, but an important negative finding that distinguishes MLS from BOR. (Direct differential point.) orpha.net

19. Unknown single-gene variant acting in a dominant fashion—suspected from the family pattern but not yet mapped. (Direct MLS inference from inheritance.) onlinelibrary.wiley.com

20. Different from BOR/BO genes (EYA1, SIX1, SIX5)—these are well-known in a related syndrome with kidneys involved; their presence would suggest BOR, not MLS. (Differential genetics.) NCBI

Symptoms and signs

1. Hearing loss at birth—may be conductive, sensorineural, or mixed; early testing is essential. orpha.net

2. Branchial cysts or fistulas—soft swellings or small openings on the side of the neck that can drain. orpha.net

3. Ear malformations—outer, middle, or inner ear differences seen on exam or imaging. orpha.net

4. Narrow internal auditory canals—seen on CT/MRI and linked to hearing loss. onlinelibrary.wiley.com

5. Preauricular tags or pits—small skin tags or dimples near the ear. onlinelibrary.wiley.com

6. Strabismus—eyes that do not align correctly. orpha.net

7. Trismus—tight jaw opening or reduced mouth opening. orpha.net

8. Abnormal fifth fingers—unusual shape or position of little fingers. orpha.net

9. Short stature—height less than expected for age. orpha.net

10. Vitiligo-like skin patches—light patches of skin color. orpha.net

11. Mild learning difficulties—need for educational support. orpha.net

12. Asymmetric ear shape—ears may be low-set or dysplastic. cags.org.ae

13. No kidney or urinary tract problems—this absence helps doctors make the MLS diagnosis rather than BOR. orpha.net

14. Possible recurrent neck infections—if a fistula or cyst becomes infected. (General branchial anomaly course.) International Surgery Journal

15. Family history in a dominant pattern—an affected parent and child in the reported family. onlinelibrary.wiley.com

Diagnostic tests

A) Physical examination

1. Comprehensive newborn and childhood exam—look for neck pits/fistulas, ear shape changes, small skin tags, finger differences, eye alignment, and growth. This baseline exam guides all later tests. orpha.net

2. Otoscopy and ear exam—check the ear canal and eardrum for structural clues to conductive loss. MSD Manuals

3. Skin and limb inspection—note vitiligo-like patches and fifth-finger changes linked to MLS summaries. orpha.net

4. Cervical (neck) exam—palpate along the anterior border of the sternocleidomastoid muscle for cysts or draining tracts. PMC

5. Family pedigree—map who is affected across generations to confirm possible autosomal-dominant inheritance. onlinelibrary.wiley.com

B) Manual (bedside) tests

6. Tuning-fork tests (Rinne and Weber)—simple bedside tools to separate conductive from sensorineural loss early on. MSD Manuals

7. Mouth opening measurement—screens for trismus severity and tracks change over time. (Phenotype noted; standard maxillofacial measure.) orpha.net

8. Cover–uncover test—quick strabismus screen in clinic. (Pediatric ophthalmology standard.) orpha.net

9. Neck fistula probing by specialists—only when indicated, to map tract before surgery; done carefully to avoid infection. (Branchial anomaly practice.) PMC

C) Laboratory and pathological tests

10. Genetic testing panel for BOR genes (EYA1, SIX1, SIX5)—useful to exclude BOR/BO if kidneys are normal; a negative result supports MLS when the phenotype matches. NCBI

11. Targeted or exome sequencing—research or clinical sequencing may be considered because the exact MLS gene is unknown; results can also find alternative diagnoses. (General rare-disease practice.) BioMed Central

12. Basic infection labs—if a branchial cyst or fistula is infected (CBC, culture). (Standard branchial-anomaly care.) International Surgery Journal

13. Pathology of excised cyst/fistula—confirms branchial origin and rules out mimics. PMC

D) Electrodiagnostic and audiologic tests

14. Otoacoustic emissions (OAE)—screens cochlear outer hair cell function in infants. Frontiers

15. Auditory brainstem response (ABR)—objective test to estimate hearing threshold and neural pathway function in babies and non-verbal children. Frontiers

16. Behavioral audiometry/tympanometry—quantifies degree and type of loss and middle-ear status over time. MSD Manuals

17. Speech and language assessment—documents functional impact of hearing loss and guides therapy. (Hearing-loss care standard.) American Academy of Audiology

E) Imaging tests

18. Temporal bone CT—defines middle-ear bones, canal anatomy, and internal auditory canal narrowing typical for MLS. onlinelibrary.wiley.com

19. Inner-ear MRI—shows cochlear nerve and inner-ear structures; complements CT. (Congenital hearing-loss imaging standard.) sciencedirect.com

20. Neck ultrasound or MRI—maps branchial cysts/fistulas before surgery. (Branchial anomaly radiology.) PMC
    (Helpful differential test) Renal ultrasound—done mainly to exclude BOR; normal kidneys favor MLS. NCBI

Non-pharmacological treatments (therapies & other measures)

1. Early newborn hearing screening follow-through — If the first screen is failed, rapid referral to audiology confirms loss early so help starts during the key window for language. Purpose: prevent language delay. Mechanism: early detection enables timely hearing devices and therapy. orpha.net

2. Hearing aids (air or bone-conduction) — Devices make sounds louder and clearer based on the child’s type of hearing loss. Purpose: improve access to speech and environmental sounds. Mechanism: amplifies sound or conducts vibration through bone when ear canal/ossicles are malformed. orpha.net

3. Cochlear implantation (for severe/profound SNHL) — An internal electrode stimulates the hearing nerve directly. Purpose: provide hearing when inner-ear function is poor. Mechanism: converts sound to electrical signals sent to the cochlear nerve. (Surgeons confirm internal auditory canal anatomy first.) orpha.net

4. Speech-language therapy — Regular therapy teaches listening skills, speech production, and language. Purpose: reduce communication delays. Mechanism: structured practice strengthens brain pathways for speech/language. orpha.net

5. Educational accommodations (IEP/504) — Classroom supports (preferential seating, FM systems, captioning). Purpose: equal learning access. Mechanism: improves signal-to-noise and visual access to instruction. rarediseases.info.nih.gov

6. FM/remote microphone systems — Teacher wears a microphone that streams voice to the student’s device. Purpose: improve hearing in noise. Mechanism: reduces distance/noise effects. rarediseases.info.nih.gov

7. Surgical excision of branchial cysts/fistulae — Planned removal prevents infection and discharge. Purpose: durable control of neck lesions. Mechanism: complete tract excision reduces recurrence. orpha.net

8. Otoplasty/auricular reconstruction (when indicated) — Reshapes malformed pinna for function and appearance. Purpose: improve ear contour and ear-mold fitting. Mechanism: cartilage/soft-tissue reconstruction. orpha.net

9. Canalplasty/meatoplasty (selected cases) — Widens or reconstructs external canal if stenotic/atretic. Purpose: improve sound conduction and ear hygiene. Mechanism: creates/expands canal lumen. orpha.net

10. Strabismus management — Glasses, patching, or surgery to align eyes. Purpose: protect binocular vision. Mechanism: corrects muscle imbalance. orpha.net

11. Jaw physiotherapy (for trismus) — Gentle stretches and devices increase mouth opening. Purpose: better feeding, dental care, and speech. Mechanism: gradual soft-tissue lengthening and joint mobility. orpha.net

12. Regular otologic care — Wax management, surveillance for otitis media/externa. Purpose: protect residual hearing. Mechanism: reduces conductive components and infections. orpha.net

13. Vision supports — Corrective lenses and low-vision strategies if needed. Purpose: optimize sensory inputs when hearing is limited. Mechanism: compensatory enhancement of visual pathways. orpha.net

14. Genetic counseling for families — Clarifies inheritance risk and testing options, even if gene is unknown. Purpose: informed family planning. Mechanism: pedigree review and risk estimates. orpha.net

15. Psychosocial support — Counseling and parent training for coping and advocacy. Purpose: reduce stress; improve adherence. Mechanism: skills building and community connection. rarediseases.info.nih.gov

16. Protective communication strategies — Face-to-face speaking, clear articulation, good lighting. Purpose: maximize understanding. Mechanism: lip-reading and visual cues support auditory input. rarediseases.info.nih.gov

17. Infection-prevention hygiene — Handwashing; keep ears dry after swimming when prone to otitis externa. Purpose: fewer infections. Mechanism: reduces pathogen exposure/moisture. orpha.net

18. Vaccination (routine) — On-time childhood vaccines (e.g., pneumococcal, influenza) to lower risk of ear/sinus infections. Purpose: protect vulnerable hearing. Mechanism: immune priming. rarediseases.info.nih.gov

19. Multidisciplinary care pathways — Coordinated ENT/audiology/ophthalmology/surgery/therapy visits. Purpose: timely, seamless care. Mechanism: shared plans and milestones. orpha.net

20. Transition planning to adult care — Plan for long-term device maintenance and eye/jaw follow-up. Purpose: sustained outcomes. Mechanism: structured handover and education. rarediseases.info.nih.gov

---

Drug treatments

There is no medicine that cures the syndrome itself. Drugs are used to treat associated problems (ear infections, allergic rhinitis, pain) to protect hearing and comfort. Below are examples commonly used in ENT care, each linked to FDA labeling for evidence. Doses must be individualized by clinicians.

1) Amoxicillin-clavulanate (AUGMENTIN) — Broad-spectrum oral antibiotic for acute otitis media or sinusitis when indicated. Class: β-lactam/β-lactamase inhibitor. Typical pediatric dosing/time: per weight, given q12h with food; duration 5–10 days per guideline. Purpose: clear bacterial ear/sinus infection quickly. Mechanism: amoxicillin blocks cell-wall synthesis; clavulanate inhibits β-lactamases. Side effects: diarrhea, rash; rare allergy. FDA Access Data

2) Ofloxacin otic 0.3% (FLOXIN Otic) — Topical antibiotic drops for otitis externa or chronic suppurative otitis media with tubes. Class: fluoroquinolone. Dosing: several drops in affected ear(s) daily per label for 7–14 days. Purpose: treat canal/middle-ear infection while avoiding systemic effects. Mechanism: inhibits bacterial DNA gyrase/topoisomerase IV. Side effects: local irritation; rare hypersensitivity. FDA Access Data

3) Ciprofloxacin/dexamethasone otic (CIPRODEX) — Combines antibiotic with anti-inflammatory steroid for AOE or AOM with tubes. Class: fluoroquinolone + corticosteroid. Dosing: 4 drops twice daily for 7 days (per label). Purpose: faster pain reduction and infection control. Mechanism: ciprofloxacin kills bacteria; dexamethasone reduces canal inflammation. Side effects: pruritus, discomfort; rare hypersensitivity. FDA Access Data

4) Azithromycin (ZITHROMAX) — Alternative macrolide for some ENT infections in penicillin-allergic patients. Class: macrolide. Dosing/time: once-daily short courses; pediatric dosing by weight. Purpose: treat bacterial pharyngitis/otitis media when appropriate. Mechanism: blocks bacterial 50S ribosome. Side effects: GI upset; QT prolongation risk. FDA Access Data

5) Fluticasone propionate nasal spray (FLONASE) — For allergic rhinitis/eustachian tube dysfunction symptoms that worsen hearing in noise. Class: intranasal corticosteroid. Dosing: once daily per age. Purpose: reduce nasal inflammation, congestion. Mechanism: local glucocorticoid anti-inflammatory action. Side effects: epistaxis, nasal irritation; rare septal perforation. FDA Access Data+1

6) Acetaminophen — Analgesic/antipyretic for ear pain or post-operative discomfort. Class: analgesic/antipyretic. Dosing: weight-based every 4–6 h (max daily per age). Purpose: comfort and fever control. Mechanism: central COX inhibition. Side effects: overdose hepatotoxicity. (See FDA OTC labeling.) Office of Dietary Supplements

7) Ibuprofen — NSAID for pain/inflammation in ear disorders or after surgery (if not contraindicated). Class: NSAID. Dosing: weight-based every 6–8 h with food. Purpose: pain relief, anti-inflammatory effect. Mechanism: COX inhibition. Side effects: GI upset; renal risk in dehydration. (FDA OTC labeling.) Office of Dietary Supplements

8) Cetirizine or Loratadine — Non-sedating antihistamines for allergic symptoms around the Eustachian tube/nasal cavity. Class: H1 antagonists. Dosing: once daily. Purpose: reduce rhinorrhea/itching that can worsen hearing in noise. Mechanism: blocks histamine at H1 receptors. Side effects: drowsiness (less common), dry mouth. (FDA labeling for OTC antihistamines.) Office of Dietary Supplements

9) Mometasone nasal spray — Another intranasal steroid option. Class: corticosteroid. Dosing: once daily. Purpose/mechanism: as with fluticasone; choose based on availability/tolerance. Side effects: epistaxis, irritation. (FDA labeling.) Office of Dietary Supplements

10) Ofloxacin ophthalmic (when eye infections occur) — For bacterial conjunctivitis if present. Class: fluoroquinolone. Dosing: drops several times daily for 7–10 days. Purpose: quickly clear bacterial eye infection that could complicate strabismus care. Mechanism: DNA gyrase inhibition. Side effects: local irritation. FDA Access Data

Why only symptomatic drugs? Because current evidence describes this syndrome as a structural/developmental anomaly without a specific molecular target; care follows standard ENT/ophthalmology protocols tailored to each patient. orpha.net

---

Dietary molecular supplements

1. Vitamin D3 — Supports bone and immune function; helpful for children with limited outdoor activity after ear surgeries. Typical maintenance 400–600 IU/day in children (higher only if prescribed). Mechanism: regulates calcium/phosphate and immune signaling. Risks: toxicity with excess. Office of Dietary Supplements+1

2. Omega-3 fatty acids (EPA/DHA) — May modestly reduce inflammatory responses in airways and middle ear mucosa; general cardiometabolic benefits. Common doses 250–500 mg/day EPA+DHA (diet first). Mechanism: pro-resolving lipid mediators. Risks: GI upset, fishy aftertaste. Office of Dietary Supplements

3. Zinc — Key for immune defenses and wound healing post-op. Pediatric doses vary; avoid excess. Mechanism: cofactor for many enzymes in immunity and repair. Risks: nausea, copper deficiency with high doses. Office of Dietary Supplements

4. Vitamin C — General antioxidant support around infection episodes; food-first approach. Mechanism: redox cofactor. Risks: GI discomfort at high doses. (NIH ODS guidance.) Office of Dietary Supplements

5. Probiotics (selected strains) — May reduce antibiotic-associated diarrhea and some URTI episodes in children. Mechanism: microbiome modulation. Discuss strain/dose with clinician. (General evidence summaries.) Office of Dietary Supplements

6. Magnesium — Supports muscle/nerve function; helpful if diet is low. Mechanism: cofactor in hundreds of enzymatic reactions. Use RDAs; avoid excess in renal impairment. Office of Dietary Supplements

7. Calcium (with Vitamin D as indicated) — Skeletal support in growing children, especially with low dairy intake. Mechanism: bone mineralization. Risks: constipation; avoid unnecessary high doses. Office of Dietary Supplements

8. Multivitamin at RDA levels — Safety net for picky eaters after surgeries/illnesses; not a treatment. Mechanism: broad micronutrient coverage. Choose age-appropriate products. Office of Dietary Supplements

9. Selenium (dietary) — Antioxidant enzymes; ensure adequate intake from food (e.g., fish, eggs, grains). Avoid high-dose supplements unless prescribed. Office of Dietary Supplements

10. Iodine (dietary) — Thyroid and growth support via iodized salt or seafood; avoid supplemental excess. Office of Dietary Supplements

---

Immunity booster / regenerative / stem-cell drugs

There are no stem-cell drugs for this syndrome. Safe, realistic supports focus on vaccines and adequate nutrition. Below are clinician-guided items sometimes called “immune support,” explained clearly:

1. Seasonal influenza vaccine — Reduces flu risk, which can trigger ear/sinus complications. Dose/schedule per age. Mechanism: antibody-mediated protection. rarediseases.info.nih.gov

2. Pneumococcal vaccines (PCV/PPSV) — Prevents pneumococcal disease that can involve ears/sinuses. Schedule per age/risk. Mechanism: serotype-specific antibodies. rarediseases.info.nih.gov

3. COVID-19 vaccination (age-eligible) — Lowers severe respiratory illness that may worsen ENT status. Mechanism: spike-specific immunity. Follow national guidance. rarediseases.info.nih.gov

4. Vitamin D (see above) — Immune modulatory effects at sufficient levels, not a cure. Dose individualized. Office of Dietary Supplements

5. Zinc (see above) — Enzyme cofactor in immunity; avoid high doses. Office of Dietary Supplements

6. Probiotics (see above) — May reduce URTIs and antibiotic-associated diarrhea in some children. Office of Dietary Supplements

---

Surgeries (what they do and why)

1) Branchial cyst/fistula excision — Removes the cyst and entire tract to prevent infection and drainage. Done through small neck incisions; mapping may use dye or imaging. Why: durable cure and lower recurrence. orpha.net

2) Otoplasty/auricular reconstruction — Rebuilds ear shape with cartilage frameworks or implants. Why: improve sound capture, fit devices, and appearance. orpha.net

3) Canalplasty/meatoplasty — Enlarge or create an external auditory canal if stenotic/atretic. Why: better sound conduction and hygiene, easier hearing-aid use. orpha.net

4) Cochlear implant surgery — Places internal receiver and electrode into the cochlea after imaging confirms nerve pathway. Why: sound access in severe/profound SNHL. orpha.net

5) Strabismus surgery — Adjusts extraocular muscles to align the eyes. Why: improve binocular vision and reduce amblyopia risk. orpha.net

---

Preventions (practical)

1. Complete newborn hearing screening follow-up and early audiology visits. orpha.net

2. Keep routine vaccines up to date (including flu). rarediseases.info.nih.gov

3. Avoid second-hand smoke to reduce ear infection risk. rarediseases.info.nih.gov

4. Dry ear care after swimming if prone to otitis externa. orpha.net

5. Treat allergic rhinitis to reduce Eustachian tube problems. FDA Access Data

6. Good hand hygiene to limit respiratory infections. rarediseases.info.nih.gov

7. Regular ENT/audiology checks to catch changes early. orpha.net

8. Eye exams to monitor and treat strabismus promptly. orpha.net

9. Protective classroom strategies (FM systems, seating). rarediseases.info.nih.gov

10. Family genetic counseling for future pregnancy planning. orpha.net

---

When to see a doctor (red flags)

See a clinician urgently for fever with severe ear pain or drainage, sudden hearing drop, swelling/redness over a neck cyst, new facial weakness, worsening eye deviation or double vision, jaw pain with inability to open the mouth, or speech regression. These can signal infection, pressure effects, or device complications that benefit from rapid treatment. orpha.net

---

What to eat & what to avoid

Eat more: balanced meals with fruits, vegetables, whole grains, iodized salt, dairy or fortified alternatives (for calcium and vitamin D), fish 1–2×/week for omega-3s, and adequate protein for healing after surgeries. These help immune function and growth. Office of Dietary Supplements+1

Limit/avoid: sugary drinks and ultra-processed snacks (inflammation/low nutrients), excess salt (unless advised for iodized intake), very hot/spicy foods right after oral/ear surgery, and supplement megadoses without clinician advice (risk of toxicity, e.g., vitamin D or zinc). Office of Dietary Supplements+1

---

Frequently asked questions (FAQ)

1) Is there a gene test for Mégarbané–Loiselet syndrome?
No single causative gene has been established because the syndrome has only been reported in one family; diagnosis is clinical plus imaging. Genetic counseling still helps families understand risk. orpha.net

2) How is it different from branchio-oto-renal (BOR) syndrome?
BOR often includes kidney/urinary anomalies; Mégarbané–Loiselet notably lacks renal/ureteral defects. orpha.net

3) Will my child always have hearing loss?
Hearing loss is common and can be conductive, sensorineural, or mixed; with early devices and therapy many children develop strong communication skills. orpha.net

4) Are surgeries always needed?
Not always. Branchial cysts/fistulae often benefit from removal; ear or eye surgeries depend on anatomy and function. orpha.net

5) Can cochlear implants work if the internal auditory canal is small?
Imaging first assesses the nerve and cochlea; candidacy is individualized in experienced centers. orpha.net

6) Do allergy sprays help hearing?
Intranasal corticosteroids can ease nasal inflammation and help Eustachian tube function in allergic rhinitis, improving comfort and listening in noise. FDA Access Data

7) Are antibiotics always required for ear infections?
No. Clinicians follow pediatric ENT guidelines; some mild cases can be observed, while others need topical or oral antibiotics. FDA Access Data+1

8) Do vaccines matter for an ear condition?
Yes. Vaccines lower risks of respiratory and some ear infections that can worsen hearing. rarediseases.info.nih.gov

9) Will my child’s learning be normal?
Most reported cases show mild learning issues at most; early hearing support and school accommodations help learning thrive. orpha.net

10) Is this the same as “neonatal progeroid syndrome” reported by Mégarbané & Loiselet?
No—an earlier paper by the same authors described a severe neonatal progeroid presentation, which is distinct. The term Mégarbané–Loiselet syndrome in modern databases refers to branchiogenic deafness syndrome. PubMed+2onlinelibrary.wiley.com+2

11) Will diet change the condition?
Diet doesn’t change the genetics, but adequate vitamin D, calcium, protein, and omega-3s support growth, healing, and general health. Office of Dietary Supplements+1

12) Are “immune boosters” necessary?
Focus on vaccines, good sleep, nutrition, and hand hygiene. Avoid unproven high-dose supplements. rarediseases.info.nih.gov+1

13) Can hearing get worse over time?
It can change with infections or device issues; regular audiology follow-up catches problems early. orpha.net

14) What specialists should be on our team?
ENT/otology, audiology, speech-language therapy, ophthalmology/strabismus, craniofacial/plastic surgery, dentistry/oral surgery, genetics, and education services. orpha.net

15) Where can clinicians read more?
See concise summaries in Orphanet, GARD/NIH, Monarch/Global Genes. globalgenes.org+3orpha.net+3rarediseases.info.nih.gov+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 02, 2025.